Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Company

Watchfrog Laboratory


1, rue Pierre Fontaine – Campus 3 – Building 3
91000 EVRY – FRANCE
Phone: +33 1 69 36 11 15
Email: info@watchfrog.fr

Gregory LEMKINE: CEO
Web Site >
In the Watchfrog lab - Tétard Bioluminescence In the Watchfrog lab - Tétard Bioluminescence

#Biomanufacturing / Pharmaceutical Services #Industrial Biotech

  • In vivo
  • Toxicity
  • Environment
  • Endocrine

Field of Activity


WatchFrog markets in vivo biotechnological solutions for environmental risk assessment and the evaluation of the therapeutic, toxic or pollutant potential of all types of chemical, cosmetic or pharmaceutical compounds.

BACKGROUND

WatchFrog is a service and contract testing provider for major industrial customers, all of whom are world leaders in their respective fields: water, energy, consumer goods, fine chemicals and pharmaceuticals.

WatchFrog has a routine screening platform that meets the quality standards required by its industrial customers.

DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY

  • In the environmental sector, WatchFrog offers modular systems for the real-time monitoring of the presence of pollutants.
  • For the environmental, chemical and pharmaceutical sectors, WatchFrog has its own automated screening platform (with a throughput of several hundred samples over a few hours). Moreover, WatchFrog sells routine tests for the screening of endocrine-disrupting properties of chemical compounds under the European Union’s REACH legislation and Water Framework Directive.
  • WatchFrog can also create dedicated disease models for the pharmaceutical industry.

CUSTOMER REFERENCES / COLLABORATIONS / HIGHLIGHTS

  • Collaboration agreement with the Environmental Protection Agency (USA EPA) as part of the TOXCAST program for prioritizing the toxicity testing of large numbers of chemicals.
  • Participation in two projects of the French National Research Program on Endocrine Disruptors (PNPRE).
  • Coordination of a hospital effluent monitoring station.
    This project is accredited by the Medicen Paris Region and DREAM clusters; the goal is to develop a tool for the on-site monitoring of toxicants in hospital effluents.

COLLABORATIONS SOUGHT
In view of the flexibility of WatchFrog’s technology, we are looking for industrial partners to take up new challenges in lead optimization or environmental risk evaluation.

  • Further Information

    Annual turnover: €900K
    2 patents
    14 staff members

    Strengths:
    Miniature, industrializable vertebrate models.
    A technology platform that complies with international quality standards for the production of aquatic material and molecular screening.

    Innovation assets:
    Real-time monitoring of environmental risks on industrial sites.

    Other facts:
    the creation of custom disease models.

Share
Genopole’s Companies

#Industrial Biotech


In same field

The VERY Food Co

Activity of research, sale, production, distribution and marketing of all unregulated food and agri-food products.

Discover
STH Biotech - Genopole's company

STH Biotech

STH BIOTECH is developing an innovative cannabis-based process for the reliable and sustainable production of active compounds for the well-being and healthcare sectors.

Discover
Synovance - entreprise généopolitaine

Synovance

Synovance has developed a revolutionary synthetic genomics platform for the conception of robust industrial bioproduction strains.

Discover
FABMID - entreprise génopolitaine

FABMID

We develop an in vitro manufactured targeted DNA vector to improve the efficiency of therapeutic cell transfection and to reduce the cost of gene-based therapies.

Discover
Altar - entreprise génopolitaine - intégre le groupe Ginko Bioworks

Altar

Ginkgo Bioworks is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.

Discover
Yposkesi - Genopole's Company

Yposkesi

YposKesi is the first French company to develop and manufacture gene and cell therapy products for rare diseases.

Discover
Pharming - Genopole's company - Logo 2021

PHARMING

Pharming specializes in the production of recombinant proteins in transgenic rabbit milk.

Discover
Global Bioenergies - entreprise génopolitaine - logo 2022

Global Bioenergies

Global Bioenergies is developing a process to convert renewable resources into hydrocarbons through fermentation.

Discover
ABOLIS - entreprise génopolitaine

Abolis Biotechnologies

Abolis develops custom-order microorganisms able to produce molecules of interest via fermentation for the health, nutrition, chemistry and cosmetics sectors.

Discover
View all >
With the support from
Région île de France